|
Volumn 4, Issue SUPPL. 3, 2002, Pages 46-51
|
Prevention of fungal infection in transplantation
a |
Author keywords
Aspergillus; Candida; Fungal infection; Prevention; Prophylaxis; Transplantation
|
Indexed keywords
AMPHOTERICIN;
AMPHOTERICIN B LIPID COMPLEX;
ANTIFUNGAL AGENT;
CALCINEURIN INHIBITOR;
CYCLOSPORIN;
FLUCONAZOLE;
ITRACONAZOLE;
NYSTATIN;
AMPHOTERICIN B;
ABDOMINAL SURGERY;
ARTICLE;
ASPERGILLUS;
CANDIDA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
DIAGNOSTIC VALUE;
DRUG EFFICACY;
DRUG SAFETY;
FUNGUS GROWTH;
FUNGUS IDENTIFICATION;
GRAFT REJECTION;
HUMAN;
INCIDENCE;
INFECTION COMPLICATION;
INFECTION PREVENTION;
INFECTION RISK;
LABORATORY DIAGNOSIS;
LIVER TRANSPLANTATION;
LUNG TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MOLECULAR BIOLOGY;
MORBIDITY;
MORTALITY;
MYCOSIS;
ORGAN TRANSPLANTATION;
PATHOGENESIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
RISK FACTOR;
SIDE EFFECT;
SURGICAL STRESS;
TRANSPLANTATION;
VALIDATION PROCESS;
BASEMENT MEMBRANE;
CANDIDIASIS;
CLASSIFICATION;
CYTOMEGALIC INCLUSION BODY DISEASE;
GROWTH, DEVELOPMENT AND AGING;
METABOLISM;
MICROBIOLOGY;
PATHOLOGY;
REVIEW;
AMPHOTERICIN B;
ANTIFUNGAL AGENTS;
BASEMENT MEMBRANE;
CANDIDA;
CANDIDIASIS;
CYTOMEGALOVIRUS INFECTIONS;
FLUCONAZOLE;
HUMAN;
MYCOSES;
ORGAN TRANSPLANTATION;
RISK FACTORS;
HUMANS;
|
EID: 0036324746
PISSN: 13982273
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1399-3062.2002.00008.x Document Type: Article |
Times cited : (32)
|
References (6)
|